What are the typical presentation and diagnostic work‑up for uterine leiomyomas in women of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Presentation and Diagnosis of Uterine Leiomyomas

Uterine leiomyomas are the most common benign tumors in women of reproductive age, affecting up to 66% of women by age 50, with most being asymptomatic but symptomatic cases presenting with abnormal uterine bleeding, bulk-related symptoms, pelvic pain, or reproductive dysfunction. 1

Clinical Presentation

Symptom Patterns

  • Most leiomyomas are asymptomatic – up to 70% of women have identifiable leiomyomas at menopause without clinical problems 1
  • Symptomatic presentations depend on size, position, and number of fibroids 1
  • Key symptoms include:
    • Abnormal uterine bleeding (most common) 1
    • Bulk-related symptoms (pelvic pressure, urinary frequency, constipation) 1
    • Pelvic pain and dysmenorrhea 1
    • Reproductive issues (infertility, recurrent pregnancy loss) 1
    • Palpable abdominopelvic mass 2

Location-Specific Presentations

  • Submucosal fibroids cause the most severe bleeding and are associated with increased risks of spontaneous abortion, preterm delivery, and fertility issues 1
  • Intramural fibroids can cause abnormal bleeding and reduced implantation rates even without cavity distortion 1
  • Subserosal fibroids typically cause bulk symptoms and may become pedunculated 2

Diagnostic Work-Up

Initial Assessment

  • Physical examination should include abdominal examination, speculum examination, and bimanual pelvic evaluation to characterize location, shape, and mobility 1
  • Laboratory testing includes hemoglobin levels (to assess for anemia from bleeding) and pregnancy testing 1
  • Endometrial biopsy should be performed if menometrorrhagia is present or if there are risk factors for endometrial pathology 1

Imaging Modalities

First-Line Imaging

Transvaginal ultrasound is the first-line imaging modality for suspected leiomyomas, showing high sensitivity and specificity. 1, 3, 4

  • Standard ultrasound findings: Well-defined, solid, concentric, hypoechoic masses with variable acoustic shadowing 4
  • Doppler imaging should be routinely incorporated to evaluate internal vascularity 1
  • Limitations: Patient body habitus, uterine position, and presence of multiple fibroids or adenomyosis can limit complete visualization 1

Enhanced Ultrasound Techniques

  • Saline infusion sonohysterography is superior to transvaginal ultrasound alone for diagnosing polyps and submucosal leiomyomas, with pooled sensitivity and specificity of 0.92 and 0.89 versus 0.64 and 0.90 respectively (P<0.001) 5
  • Transvaginal ultrasound sensitivity for polyps is particularly low (0.51), making it inadequate as a standalone test to exclude intrauterine pathology 5
  • 3-D ultrasound may improve spatial assessment and treatment planning 1

MRI Indications

MRI is the most accurate imaging technique for detection and localization of leiomyomas and should be obtained when ultrasound cannot completely evaluate the endometrium or for preprocedural planning. 1, 2

  • MRI is indicated when:

    • Ultrasound cannot adequately visualize the uterus or endometrium 1
    • Precise mapping is needed for surgical or interventional planning 1, 6
    • Preprocedural workup for uterine artery embolization 1
    • Concern for leiomyosarcoma (approximately 1 in 350 women undergoing surgery for presumed fibroids) 1
  • MRI protocol essentials:

    • Diffusion-weighted imaging should be included to improve sensitivity and specificity for uterine pathology 1
    • MR angiography for preprocedural vascular mapping before embolization 1

Typical MRI Findings

  • Non-degenerated leiomyomas: Well-circumscribed masses with decreased signal intensity on T2-weighted images 2
  • Cellular leiomyomas: Higher signal intensity on T2-weighted images with enhancement on contrast-enhanced sequences 2
  • Degenerated leiomyomas: Variable appearances depending on degeneration type (hyaline, myxoid, calcification, cystic, red degeneration) 2

Classification System

The FIGO classification system should be used to standardize reporting based on fibroid relationship to the endometrium and serosa. 3

  • Submucosal (SM): Types 0-2, with varying degrees of intracavitary extension 3
  • Other (O): Types 3-8, including intramural and subserosal locations 3
  • This classification is essential for determining optimal therapeutic approach, particularly for minimally invasive techniques 3

Critical Diagnostic Pitfalls

Differential Diagnosis Considerations

  • Adenomyosis is commonly misdiagnosed as leiomyoma on ultrasound 4
  • Solid adnexal masses can mimic pedunculated subserosal fibroids 2
  • Endometrial polyps must be distinguished, particularly when evaluating abnormal bleeding 5
  • Leiomyosarcoma has the most serious consequences if misdiagnosed – no imaging technique can reliably differentiate it from benign leiomyoma, though rapid growth in postmenopausal women raises suspicion 1, 4

Follow-Up Imaging

  • Post-embolization MRI at 3-6 months is recommended to ensure adequate fibroid infarction and exclude underlying leiomyosarcoma 1
  • Incomplete fibroid infarction should be assessed with follow-up imaging to determine treatment efficacy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment.

Radiographics : a review publication of the Radiological Society of North America, Inc, 1999

Research

Ultrasonography of uterine leiomyomas.

Przeglad menopauzalny = Menopause review, 2017

Research

Etiology, diagnosis, and management of uterine leiomyomas.

Journal of midwifery & women's health, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.